Methamphetamine induces striatal cell death followed by the generation of new cells and a second round of cell death in mice

Current Neuropharmacology

Volumn 9, Issue 1, 2011, Pages 79-83

  Tulloch, I K ^a   Afanador, L ^a   Zhu, J ^a   Angulo, J A ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Cytogenesis; Methamphetamine; Neurotoxicity; Normalization; Striatal volume; Striatum

Indexed keywords

METHAMPHETAMINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN SIZE; CELL DEATH; CONTROLLED STUDY; CORPUS STRIATUM; CYTOTOXICITY; GLIA; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PHENOTYPE; STEM CELL;

EID: 79953035863     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157015911795017281     Document Type: Article

References (22)

1. United Nations Office on Drugs and Crime (UNODC). World Drug Report 2007. Vienna, Austria: UNODC Research and Analysis Section, 2007. Reference Available from: http://www.unodc.org/pdf/research/wdr07/WDR_2007.pdf [Accessed on: 27th September, 2008].
2. Ellinwood, E.H., Jr. Assault and homicide associated with amphetamine abuse. Am. J. Psychiatry, 1971, 127, 1170-1175.
3. Szuster, R.R. Methamphetamine in psychiatric emergencies. Hawaii Med. J., 1990, 49, 389-391.
4. McCann, U.D., Wong, D.E., Yokoi, E., Villemagne, V., Dannals, R.E., Ricaurte, G.A. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography. J. Neurosci., 1998, 18, 8417-8422.
5. Sekine, Y., Iyo, M., Ouchi, Y., Matsunaga, T., Tsukada, H., Okada, H., Yoshikawa, E., Futatsubashi, B.A., Takei, N., Mori, N. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am. J. Psychiatry, 2001, 158, 1206-1214.
6. Sekine, Y., Ouchi, Y., Takei, N., Yoshikawa, E., Nakamura, K., Futatsubashi, M., Okada, H., Minabe, Y., Suzuki, K., Iwata, Y., Tsuchiya, K.J., Tsukada, H., Iyo, M., Mori, N. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arc. Gen. Psychiatry, 2006, 63, 90-100.
7. Volkow, N., Chang, L., Wang, G., Fowler, J., Leonido-Yee, M., Franceschi, D., Sedler, M.J., Gatley, S. J., Hitzemann, R., Ding, Y.-S. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am. J. Psychiatry, 2001, 158, 377-382.
8. Thompson, P.M., Hayashi, K.M., Simon, S.L., Geaga, J.A., Hong, M.S., Sui, Y., Lee, J.Y., Toga, A.W., Ling, W., London, E.D. Structural abnormalities in the brains of human subjects who use methamphetamine. J. Neurosci., 2004, 24, 6028-6036.
9. Chang, L., Cloak, C., Patterson, K., Grob, C., Miller, E.N., Ernst, T. Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response. Biol. Psychiatry, 2005, 57, 967-974.
10. Jernigan, T.L., Gamst, A.C., Archibald, S.L., Fennema-Notestine, C., Mindt, M.R., Marcotte, T.L., Heaton, R.K., Ellis, R. J., Grant, I. Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am. J. Psychiatry, 2005, 162, 1461-1472.
11. Seiden, L.S., MacPhail, R.C., Oglesby, M.W. Catecholamines and drug-behavior interactions. Fed. Proc., 1975, 34, 1823-1831.
12. Woolverton, W.L., Ricaurte, G.A., Forno, L.S., Seiden, L.S. Longterm effects of chronic methamphetamine administration in rhesus monkeys. Brain Res., 1989, 486, 73-78.
13. Hanson, G.R., Gibb, J.W., Metzger, R.R., Kokoshka, J.M., Fleckenstein, A.E. Methamphetamine-induced rapid and reversible reduction in the activities of tryptophan hydroxylase and dopamine transporters: oxidative consequences. Ann. N.Y. Acad. Sci., 1998, 844, 103-107.
14. Ricaurte, G.A., Guillery, R.W., Seiden, L.S., Schuster, C.R., Moore, R.Y. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res., 1982, 235, 93-103.
15. Deng, X., Wang, Y., Chou, J., Cadet, J.L. Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method. Brain Res. Mol. Brain Res., 2001, 93, 64-69.
16. Eisch, A.J., Marshall, J.F. Methamphetamine neurotoxicity: dissociation of striatal dopamine terminal damage from parietal cortical cell body injury. Synapse, 1998, 30, 433-445.
17. Zhu, J.P.Q., Xu, W., Angulo, J.A. Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice. Brain Res., 2005, 1049, 171-181.
18. Franklin, K.B.J., Paxinos, G. The Mouse Brain in Stereotaxic Coordinates. The Academic Press: New York, 1997.
19. Zhu, J.P.Q., Xu, W., Angulo, J.A. Methamphetamine-induced cell death: Selective vulnerability in neuronal subpopulations of the striatum in mice. Neuroscience, 2006, 140, 607-622.
20. Bowyer, J.F., Robinson, B., Ali, S.F., Schmued, L.C. Neurotoxicrelated changes in tyrosine hydroxylase, microglia, myelin, and blood-brain barrier in the caudate-putamen from acute methamphetamine exposure. Synapse, 2008, 62, 193-204.
21. Chang, L., Alicata, D., Ernst, T., Volkow, N. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction, 2007, 102, 16-32.
22. Oh, J.S., Lyoo, I.K., Sung, Y.H., Hwang, J., Kim, J., Chung, A., Park, K.S., Kim, S.J., Renshaw, P.F., Song, I.C. Shape changes of the corpus callosum in abstinent methamphetamine users. Neurosci. Lett., 2005, 384, 76-81.